Resultados de procura - Carsten Stephan
- Mostrando 1 - 20 Resultados de 32
- Go to Next Page
-
1
-
2
Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma por Angelika Tölle, Saba Suhail, Monika Jung, Klaus Jung, Carsten Stephan
Publicado 2011Artigo -
3
-
4
-
5
-
6
-
7
Interchangeability of Measurements of Total and Free Prostate-Specific Antigen in Serum with 5 Frequently Used Assay Combinations: An Update por Carsten Stephan, Moritz Klaas, Christian Müller, Dietmar Schnorr, Stefan A. Loening, Klaus Jung
Publicado 2006Artigo -
8
-
9
-
10
Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSA... por Ilka Kristiansen, Carsten Stephan, Klaus Jung, Manfred Dietel, Anja Rieger, Yuri Tolkach, Glen Kristiansen
Publicado 2017Artigo -
11
-
12
-
13
Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: Diagnostic and prognostic implications por Klaus Jung, Michael Lein, Carsten Stephan, Katharina von Hößlin, Axel Semjonow, Pranav Sinha, Stefan A. Loening, Dietmar Schnorr
Publicado 2004Artigo -
14
Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p por Zofia Wotschofsky, Linda Gummlich, Julia Liep, Carsten Stephan, Ergin Kilic, Klaus Jung, Jean-Noël Billaud, Hellmuth‐Alexander Meyer
Publicado 2016Artigo -
15
Areas Suspicious for Prostate Cancer: MR–guided Biopsy in Patients with at Least One Transrectal US-guided Biopsy with a Negative Finding—Multiparametric MR Imaging for Detection a... por Tobias Franiel, Carsten Stephan, Andreas Erbersdobler, Ekkehart Dietz, Andreas Maxeiner, Nina Hell, Alexander Huppertz, Kurt Miller, Ralph Strecker, Bernd Hamm
Publicado 2011Artigo -
16
Circular RNAs in Clear Cell Renal Cell Carcinoma: Their Microarray-Based Identification, Analytical Validation, and Potential Use in a Clinico-Genomic Model to Improve Prognostic A... por Antonia Franz, Bernhard Ralla, Sabine Weickmann, Monika Jung, Hannah Rochow, Carsten Stephan, Andreas Erbersdobler, Ergin Kilic, Annika Fendler, Klaus Jung
Publicado 2019Artigo -
17
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma por Annika Schaefer, Monika Jung, Hans‐Joachim Mollenkopf, Ina Wagner, Carsten Stephan, Florian Jentzmik, Kurt Miller, Michael Lein, Glen Kristiansen, Klaus Jung
Publicado 2009Artigo -
18
Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma por Isrid Sturm, Carsten Stephan, Bernhard Gillissen, Reiner Siebert, Martin Janz, Silke Radetzki, Klaus Jung, S.A. Loening, Bernd Dörken, P T Daniel
Publicado 2005Artigo -
19
GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics por Glen Kristiansen, F. Fritzsche, K Wassermann, Christian Jäger, Angelika Tölle, Michael Lein, Carsten Stephan, Klaus Jung, Christian Pilarsky, Manfred Dietel, Holger Moch
Publicado 2008Artigo -
20
Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort por Raquel Esgueva, Sven Perner, Christopher J. Lafargue, Veit Scheble, Carsten Stephan, Michael Lein, Florian Fritzsche, Manfred Dietel, Glen Kristiansen, Mark A. Rubin
Publicado 2010Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Cancer
Internal medicine
Biology
Prostate cancer
Gene
Prostate
Cancer research
Pathology
Genetics
Oncology
Biochemistry
Prostate-specific antigen
Prostatectomy
Renal cell carcinoma
microRNA
Gene expression
Immunohistochemistry
PCA3
Urology
Carcinogenesis
Computational biology
Computer science
Erg
Kidney cancer
Messenger RNA
Retinal
Apoptosis
Bioinformatics
Biomarker